Industries > Pharma > Biological Imaging Reagents Market Report 2021-2031
Biological Imaging Reagents Market Report 2021-2031
Forecasts By Product Type (Contrast Reagents, Nuclear Reagents, Optical Imaging Reagents, Fluorescent Dyes and Probes, and Others Reagents), By Form (Injectable, Tablet, Suspension, and Others), By Application (In Vitro, and In Vivo), By Technology Type (Nanotechnology, Biologic Targeting, Microfluidics, Supramolecular Chemistry, Protein Engineering, and Others), By End-User (Diagnostic Laboratories, Imaging Centers, Life Sciences Companies, Academic & Research Institutes, and Others), By Distribution Channel (Direct Tender, and Retail Sales), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios
Biological Imaging Reagents Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Biological Imaging Reagents is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 250+ page report provides 400+ tables and 400+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biological Imaging Reagents Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Revenue and growth forecasts from 2021 to 2031 for the Global Biological Imaging Reagents Market By Product Type
• Contrast Reagents
o MRI Reagents
o Ultrasound Reagents
o X-ray Reagents
o CT Reagents
• Nuclear Reagents
o PET Reagents
o SPECT Reagents
• Optical Imaging Reagents
• Fluorescent Dyes and Probes
• Others Reagents
Revenue and growth forecasts from 2021 to 2031 for the Global Biological Imaging Reagents Market By Form
• Injectable
• Tablet
• Suspension
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Biological Imaging Reagents Market By Application
• In Vitro
o Proteomics
o Genomics
o Cell Biology
• In Vivo
Revenue and growth forecasts from 2021 to 2031 for the Global Biological Imaging Reagents Market By Technology Type
• Nanotechnology
• Biologic Targeting
• Microfluidics
• Supramolecular Chemistry
• Protein Engineering
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Biological Imaging Reagents Market By End-User
• Diagnostic Laboratories
• Imaging Centers
• Life Sciences Companies
• Academic & Research Institutes
• Others
Revenue and growth forecasts from 2021 to 2031 for the Global Biological Imaging Reagents Market By Distribution Channel
• Direct Tender
• Retail Sales
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Biological Imaging Reagents Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Biological Imaging Reagents Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biological Imaging Reagents Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Biological Imaging Reagents Market, with forecasts for Get our report today Biological Imaging Reagents Market Forecast 2021-2031: By Product Type, Form, Application, Technology Type, End-User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Biological Imaging Reagents market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Biological Imaging Reagents Market. Some of the company’s profiled in this report include
• Bayer AG
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• Guerbet
• Lantheus Holdings, Inc.
• Bracco S.p.A.
• GE Healthcare
• BD
• Siemens Healthineers
• Luminex Corporation
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Biological Imaging Reagents Market Report 2021-2031: Forecasts By Product Type (Contrast Reagents, Nuclear Reagents, Optical Imaging Reagents, Fluorescent Dyes and Probes, and Others Reagents), By Form (Injectable, Tablet, Suspension, and Others), By Application (In Vitro, and In Vivo), By Technology Type (Nanotechnology, Biologic Targeting, Microfluidics, Supramolecular Chemistry, Protein Engineering, and Others), By End-User (Diagnostic Laboratories, Imaging Centers, Life Sciences Companies, Academic & Research Institutes, and Others), By Distribution Channel (Direct Tender, and Retail Sales), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Biological Imaging Reagents Market
2.1. Biological Imaging Reagents Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Form Submarkets Definitions
3. Biological Imaging Reagents Market Overview
3.1. Global Biological Imaging Reagents Market Size and Forecast By Region
3.2. Global Biological Imaging Reagents Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing prevalence of Cardiovascular Diseases
3.3.1.2. Increasing number of diagnostic imaging procedures
3.3.1.3. Increasing strategic initiatives in Biological Imaging Reagents market
3.3.1.4. Rise in the number of diagnostic imaging procedure
3.3.1.5. Surging investment in research activities
3.3.2. Market Restraints
3.3.2.1. Product recall
3.3.2.2. Stringent regulation associated with product development
3.3.2.3. High cost of development
3.3.3. Opportunities
3.3.3.1. Technological advancements in biological imaging reagents
3.3.3.2. Increasing strategic initiatives in biological imaging reagents market
3.3.4. Challenges
3.3.4.1. Increasing competition in the market
3.3.4.2. Availability of alternatives
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Biological Imaging Reagents Market Analysis and Forecast 2021-2031, By Technology Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Contrast Reagents
4.1.1.1. Contrast Reagents market size and forecast, 2021-2031 (USD Million)
4.1.2. Nuclear Reagents
4.1.2.1. Nuclear Reagents market size and forecast, 2021-2031 (USD Million)
4.1.3. Optical Imaging Reagents
4.1.3.1. Optical Imaging Reagents market size and forecast, 2021-2031 (USD Million)
4.1.4. Fluorescent Dyes and Probes
4.1.4.1. Fluorescent Dyes and Probes market size and forecast, 2021-2031 (USD Million)
4.1.5. Others Reagents
4.1.5.1. Others Reagents market size and forecast, 2021-2031 (USD Million)
5. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Form (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Injectable
5.1.1.1. Injectable market size and forecast, 2021-2031 (USD Million)
5.1.2. Tablet
5.1.2.1. Tablet market size and forecast, 2021-2031 (USD Million)
5.1.3. Suspension
5.1.3.1. Suspension market size and forecast, 2021-2031 (USD Million)
5.1.4. Others
5.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. In Vitro
6.1.1.1. In Vitro market size and forecast, 2021-2031 (USD Million)
6.1.2. In Vivo
6.1.2.1. In Vivo Market size and forecast, 2021-2031 (USD Million)
7. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Technology Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Nanotechnology
7.1.1.1. Nanotechnology market size and forecast, 2021-2031 (USD Million)
7.1.2. Biologic Targeting
7.1.2.1. Biologic Targeting market size and forecast, 2021-2031 (USD Million)
7.1.3. Microfluidics
7.1.3.1. Microfluidics market size and forecast, 2021-2031 (USD Million)
7.1.4. Supramolecular Chemistry
7.1.4.1. Supramolecular Chemistry Market size and forecast, 2021-2031 (USD Million)
7.1.5. Protein Engineering
7.1.5.1. Protein Engineering market size and forecast, 2021-2031 (USD Million)
7.1.6. Others
7.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Diagnostic Laboratories
8.1.1.1. Diagnostic Laboratories market size and forecast, 2021-2031 (USD Million)
8.1.2. Imaging Centers
8.1.2.1. Imaging Centers market size and forecast, 2021-2031 (USD Million)
8.1.3. Life Sciences Companies
8.1.3.1. Life Sciences Companies market size and forecast, 2021-2031 (USD Million)
8.1.4. Academic & Research Institutes
8.1.4.1. Academic & Research Institutes market size and forecast, 2021-2031 (USD Million)
8.1.5. Others
8.1.5.1. Others Market size and forecast, 2021-2031 (USD Million)
9. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Direct Tender
9.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
9.1.2. Retail Sales
9.1.2.1. Retail Sales Market size and forecast, 2021-2031 (USD Million)
10. North America Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. North America Biological Imaging Reagents Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. North America Biological Imaging Reagents Market Size and Forecast By Form
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. North America Biological Imaging Reagents Market Size and Forecast By Application
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. North America Biological Imaging Reagents Market Size and Forecast By Technology Type
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. North America Biological Imaging Reagents Market Size and Forecast By End-User
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. North America Biological Imaging Reagents Market Size and Forecast By Distribution Channel
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. U.S. Biological Imaging Reagents Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. Canada Biological Imaging Reagents Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
11. Europe Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Europe Biological Imaging Reagents Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Europe Biological Imaging Reagents Market Size and Forecast By Form
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Europe Biological Imaging Reagents Market Size and Forecast By Application
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Europe Biological Imaging Reagents Market Size and Forecast By Technology Type
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Europe Biological Imaging Reagents Market Size and Forecast By End-User
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. Europe Biological Imaging Reagents Market Size and Forecast By Distribution Channel
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. UK Biological Imaging Reagents Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Germany Biological Imaging Reagents Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. France Biological Imaging Reagents Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
11.11. Rest of Europe Biological Imaging Reagents Market
11.11.1.1. XX Driving/Opportunity Factor
11.11.1.2. XX Driving/Opportunity Factor
12. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Form
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Application
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Technology Type
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By End-User
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Distribution Channel
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. China Biological Imaging Reagents Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. India Biological Imaging Reagents Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Japan Biological Imaging Reagents Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. Rest of Asia Pacific Biological Imaging Reagents Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
13. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Latin America Biological Imaging Reagents Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Latin America Biological Imaging Reagents Market Size and Forecast By Form
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Latin America Biological Imaging Reagents Market Size and Forecast By Application
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Latin America Biological Imaging Reagents Market Size and Forecast By Technology Type
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Latin America Biological Imaging Reagents Market Size and Forecast By End-User
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Latin America Biological Imaging Reagents Market Size and Forecast By Distribution Channel
13.8. Brazil Biological Imaging Reagents Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Mexico Biological Imaging Reagents Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. Rest of Latin America Biological Imaging Reagents Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
14. MEA Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. MEA Biological Imaging Reagents Market Size and Forecast By Product Type
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. MEA Biological Imaging Reagents Market Size and Forecast By Form
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. MEA Biological Imaging Reagents Market Size and Forecast By Application
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. MEA Biological Imaging Reagents Market Size and Forecast By Technology Type
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. MEA Biological Imaging Reagents Market Size and Forecast By End-User
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. MEA Biological Imaging Reagents Market Size and Forecast By Distribution Channel
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. GCC Biological Imaging Reagents Market
14.8.1.1. XX Driving/Opportunity Factor
14.8.1.2. XX Driving/Opportunity Factor
14.9. South Africa Biological Imaging Reagents Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Rest of MEA Biological Imaging Reagents Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
15. Companies in the Biological Imaging Reagents Market
15.1. Bayer AG
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Performance (2015-2019)
15.1.3.1. Net Revenue
15.1.3.2. Gross Profit
15.1.3.3. Geographical Revenue, 2019
15.1.4. Product Offerings
15.1.5. Recent Initiatives (2017-2019)
15.2. Thermo Fisher Scientific, Inc.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Performance (2015-2019)
15.2.3.1. Net Revenue
15.2.3.2. Gross Profit
15.2.3.3. Geographical Revenue, 2019
15.2.4. Product Offerings
15.2.5. Recent Initiatives (2017-2019)
15.3. PerkinElmer, Inc.
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Performance (2015-2019)
15.3.3.1. Net Revenue
15.3.3.2. Gross Profit
15.3.3.3. Geographical Revenue, 2019
15.3.4. Product Offerings
15.3.5. Recent Initiatives (2017-2019)
15.4. Guerbet
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Performance (2015-2019)
15.4.3.1. Net Revenue
15.4.3.2. Gross Profit
15.4.3.3. Geographical Revenue, 2019
15.4.4. Product Offerings
15.4.5. Recent Initiatives (2017-2019)
15.5. Lantheus Holdings, Inc.
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Performance (2015-2019)
15.5.3.1. Net Revenue
15.5.3.2. Gross Profit
15.5.3.3. Geographical Revenue, 2019
15.5.4. Product Offerings
15.5.5. Recent Initiatives (2017-2019)
15.6. Bracco S.p.A.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Performance (2015-2019)
15.6.3.1. Net Revenue
15.6.3.2. Gross Profit
15.6.3.3. Geographical Revenue, 2019
15.6.4. Product Offerings
15.6.5. Recent Initiatives (2017-2019)
15.7. GE Healthcare
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Performance (2015-2019)
15.7.3.1. Net Revenue
15.7.3.2. Gross Profit
15.7.3.3. Geographical Revenue, 2019
15.7.4. Product Offerings
15.7.5. Recent Initiatives (2017-2019)
15.8. BD
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Performance (2015-2019)
15.8.3.1. Net Revenue
15.8.3.2. Gross Profit
15.8.3.3. Geographical Revenue, 2019
15.8.4. Product Offerings
15.8.5. Recent Initiatives (2017-2019)
15.9. Siemens Healthineers
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Performance (2015-2019)
15.9.3.1. Net Revenue
15.9.3.2. Gross Profit
15.9.3.3. Geographical Revenue, 2019
15.9.4. Product Offerings
15.9.5. Recent Initiatives (2017-2019)
15.10. Luminex Corporation
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Performance (2015-2019)
15.10.3.1. Net Revenue
15.10.3.2. Gross Profit
15.10.3.3. Geographical Revenue, 2019
15.10.4. Product Offerings
15.10.5. Recent Initiatives (2017-2019)
15.11. Other Notable Players
16. Conclusion
17. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Biological Imaging Reagents Market Drivers & Restraints 2021
Table 7. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Nanotechnology h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 148. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 153. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 203. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 382. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 383. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 384. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 385. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 386. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 387. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 388. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 389. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 390. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 391. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 392. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 393. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 394. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 395. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 396. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 397. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 398. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 399. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 400. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 401. Leading 15 Biological Imaging Reagents Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 402. Bayer AG.Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Bayer AG Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 404. Thermo Fisher Scientific, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 405. Thermo Fisher Scientific, Inc. Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 406. PerkinElmer, Inc.Profile 2019 (CEO, HQ, Founded, Website)
Table 407. PerkinElmer, Inc.Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 408. Guerbet Profile 2019 (CEO, HQ, Founded, Website)
Table 409. Guerbet Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 410. Lantheus Holdings, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 411. Lantheus Holdings, Inc. Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 412. Bracco S.p.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 413. Bracco S.p.A. Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 414. GE Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 415. GE Healthcare Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 416. BD Profile 2019 (CEO, HQ, Founded, Website)
Table 417. BD Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 418. Siemens Healthineers Profile 2019 (CEO, HQ, Founded, Website)
Table 419. Siemens Healthineers Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 420. Luminex Corporation Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 421. Luminex Corporation Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 422. Other Companies Involved in the Biological Imaging Reagents Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Biological Imaging Reagents Market Drivers & Restraints 2021
Figure 7. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 33. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Nanotechnology h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 148. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 153. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 203. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 228. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 382. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 383. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 384. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 385. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 386. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 387. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 388. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 389. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 390. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 391. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 392. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 393. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 394. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 395. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 396. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 397. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 398. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 399. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 400. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 401. Leading 10 Biological Imaging Reagents Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Figure 402. Porter’s Five Force Analysis
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Biological Imaging Reagents Market
2.1. Biological Imaging Reagents Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Form Submarkets Definitions
3. Biological Imaging Reagents Market Overview
3.1. Global Biological Imaging Reagents Market Size and Forecast By Region
3.2. Global Biological Imaging Reagents Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing prevalence of Cardiovascular Diseases
3.3.1.2. Increasing number of diagnostic imaging procedures
3.3.1.3. Increasing strategic initiatives in Biological Imaging Reagents market
3.3.1.4. Rise in the number of diagnostic imaging procedure
3.3.1.5. Surging investment in research activities
3.3.2. Market Restraints
3.3.2.1. Product recall
3.3.2.2. Stringent regulation associated with product development
3.3.2.3. High cost of development
3.3.3. Opportunities
3.3.3.1. Technological advancements in biological imaging reagents
3.3.3.2. Increasing strategic initiatives in biological imaging reagents market
3.3.4. Challenges
3.3.4.1. Increasing competition in the market
3.3.4.2. Availability of alternatives
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Biological Imaging Reagents Market Analysis and Forecast 2021-2031, By Technology Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Contrast Reagents
4.1.1.1. Contrast Reagents market size and forecast, 2021-2031 (USD Million)
4.1.2. Nuclear Reagents
4.1.2.1. Nuclear Reagents market size and forecast, 2021-2031 (USD Million)
4.1.3. Optical Imaging Reagents
4.1.3.1. Optical Imaging Reagents market size and forecast, 2021-2031 (USD Million)
4.1.4. Fluorescent Dyes and Probes
4.1.4.1. Fluorescent Dyes and Probes market size and forecast, 2021-2031 (USD Million)
4.1.5. Others Reagents
4.1.5.1. Others Reagents market size and forecast, 2021-2031 (USD Million)
5. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Form (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Injectable
5.1.1.1. Injectable market size and forecast, 2021-2031 (USD Million)
5.1.2. Tablet
5.1.2.1. Tablet market size and forecast, 2021-2031 (USD Million)
5.1.3. Suspension
5.1.3.1. Suspension market size and forecast, 2021-2031 (USD Million)
5.1.4. Others
5.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
6. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. In Vitro
6.1.1.1. In Vitro market size and forecast, 2021-2031 (USD Million)
6.1.2. In Vivo
6.1.2.1. In Vivo Market size and forecast, 2021-2031 (USD Million)
7. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Technology Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Nanotechnology
7.1.1.1. Nanotechnology market size and forecast, 2021-2031 (USD Million)
7.1.2. Biologic Targeting
7.1.2.1. Biologic Targeting market size and forecast, 2021-2031 (USD Million)
7.1.3. Microfluidics
7.1.3.1. Microfluidics market size and forecast, 2021-2031 (USD Million)
7.1.4. Supramolecular Chemistry
7.1.4.1. Supramolecular Chemistry Market size and forecast, 2021-2031 (USD Million)
7.1.5. Protein Engineering
7.1.5.1. Protein Engineering market size and forecast, 2021-2031 (USD Million)
7.1.6. Others
7.1.6.1. Others market size and forecast, 2021-2031 (USD Million)
8. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Diagnostic Laboratories
8.1.1.1. Diagnostic Laboratories market size and forecast, 2021-2031 (USD Million)
8.1.2. Imaging Centers
8.1.2.1. Imaging Centers market size and forecast, 2021-2031 (USD Million)
8.1.3. Life Sciences Companies
8.1.3.1. Life Sciences Companies market size and forecast, 2021-2031 (USD Million)
8.1.4. Academic & Research Institutes
8.1.4.1. Academic & Research Institutes market size and forecast, 2021-2031 (USD Million)
8.1.5. Others
8.1.5.1. Others Market size and forecast, 2021-2031 (USD Million)
9. Global Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Direct Tender
9.1.1.1. Direct Tender market size and forecast, 2021-2031 (USD Million)
9.1.2. Retail Sales
9.1.2.1. Retail Sales Market size and forecast, 2021-2031 (USD Million)
10. North America Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. North America Biological Imaging Reagents Market Size and Forecast By Product Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. North America Biological Imaging Reagents Market Size and Forecast By Form
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. North America Biological Imaging Reagents Market Size and Forecast By Application
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. North America Biological Imaging Reagents Market Size and Forecast By Technology Type
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. North America Biological Imaging Reagents Market Size and Forecast By End-User
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. North America Biological Imaging Reagents Market Size and Forecast By Distribution Channel
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. U.S. Biological Imaging Reagents Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. Canada Biological Imaging Reagents Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
11. Europe Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Europe Biological Imaging Reagents Market Size and Forecast By Product Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Europe Biological Imaging Reagents Market Size and Forecast By Form
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Europe Biological Imaging Reagents Market Size and Forecast By Application
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Europe Biological Imaging Reagents Market Size and Forecast By Technology Type
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Europe Biological Imaging Reagents Market Size and Forecast By End-User
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. Europe Biological Imaging Reagents Market Size and Forecast By Distribution Channel
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. UK Biological Imaging Reagents Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Germany Biological Imaging Reagents Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. France Biological Imaging Reagents Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
11.11. Rest of Europe Biological Imaging Reagents Market
11.11.1.1. XX Driving/Opportunity Factor
11.11.1.2. XX Driving/Opportunity Factor
12. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Product Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Form
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Application
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Technology Type
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By End-User
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Asia-Pacific Biological Imaging Reagents Market Size and Forecast By Distribution Channel
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. China Biological Imaging Reagents Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. India Biological Imaging Reagents Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Japan Biological Imaging Reagents Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. Rest of Asia Pacific Biological Imaging Reagents Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
13. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Latin America Biological Imaging Reagents Market Size and Forecast By Product Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Latin America Biological Imaging Reagents Market Size and Forecast By Form
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Latin America Biological Imaging Reagents Market Size and Forecast By Application
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Latin America Biological Imaging Reagents Market Size and Forecast By Technology Type
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Latin America Biological Imaging Reagents Market Size and Forecast By End-User
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Latin America Biological Imaging Reagents Market Size and Forecast By Distribution Channel
13.8. Brazil Biological Imaging Reagents Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Mexico Biological Imaging Reagents Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. Rest of Latin America Biological Imaging Reagents Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
14. MEA Biological Imaging Reagents Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. MEA Biological Imaging Reagents Market Size and Forecast By Product Type
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. MEA Biological Imaging Reagents Market Size and Forecast By Form
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. MEA Biological Imaging Reagents Market Size and Forecast By Application
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. MEA Biological Imaging Reagents Market Size and Forecast By Technology Type
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. MEA Biological Imaging Reagents Market Size and Forecast By End-User
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. MEA Biological Imaging Reagents Market Size and Forecast By Distribution Channel
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. GCC Biological Imaging Reagents Market
14.8.1.1. XX Driving/Opportunity Factor
14.8.1.2. XX Driving/Opportunity Factor
14.9. South Africa Biological Imaging Reagents Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Rest of MEA Biological Imaging Reagents Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
15. Companies in the Biological Imaging Reagents Market
15.1. Bayer AG
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Performance (2015-2019)
15.1.3.1. Net Revenue
15.1.3.2. Gross Profit
15.1.3.3. Geographical Revenue, 2019
15.1.4. Product Offerings
15.1.5. Recent Initiatives (2017-2019)
15.2. Thermo Fisher Scientific, Inc.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Performance (2015-2019)
15.2.3.1. Net Revenue
15.2.3.2. Gross Profit
15.2.3.3. Geographical Revenue, 2019
15.2.4. Product Offerings
15.2.5. Recent Initiatives (2017-2019)
15.3. PerkinElmer, Inc.
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Performance (2015-2019)
15.3.3.1. Net Revenue
15.3.3.2. Gross Profit
15.3.3.3. Geographical Revenue, 2019
15.3.4. Product Offerings
15.3.5. Recent Initiatives (2017-2019)
15.4. Guerbet
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Performance (2015-2019)
15.4.3.1. Net Revenue
15.4.3.2. Gross Profit
15.4.3.3. Geographical Revenue, 2019
15.4.4. Product Offerings
15.4.5. Recent Initiatives (2017-2019)
15.5. Lantheus Holdings, Inc.
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Performance (2015-2019)
15.5.3.1. Net Revenue
15.5.3.2. Gross Profit
15.5.3.3. Geographical Revenue, 2019
15.5.4. Product Offerings
15.5.5. Recent Initiatives (2017-2019)
15.6. Bracco S.p.A.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Performance (2015-2019)
15.6.3.1. Net Revenue
15.6.3.2. Gross Profit
15.6.3.3. Geographical Revenue, 2019
15.6.4. Product Offerings
15.6.5. Recent Initiatives (2017-2019)
15.7. GE Healthcare
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Performance (2015-2019)
15.7.3.1. Net Revenue
15.7.3.2. Gross Profit
15.7.3.3. Geographical Revenue, 2019
15.7.4. Product Offerings
15.7.5. Recent Initiatives (2017-2019)
15.8. BD
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Performance (2015-2019)
15.8.3.1. Net Revenue
15.8.3.2. Gross Profit
15.8.3.3. Geographical Revenue, 2019
15.8.4. Product Offerings
15.8.5. Recent Initiatives (2017-2019)
15.9. Siemens Healthineers
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Performance (2015-2019)
15.9.3.1. Net Revenue
15.9.3.2. Gross Profit
15.9.3.3. Geographical Revenue, 2019
15.9.4. Product Offerings
15.9.5. Recent Initiatives (2017-2019)
15.10. Luminex Corporation
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Performance (2015-2019)
15.10.3.1. Net Revenue
15.10.3.2. Gross Profit
15.10.3.3. Geographical Revenue, 2019
15.10.4. Product Offerings
15.10.5. Recent Initiatives (2017-2019)
15.11. Other Notable Players
16. Conclusion
17. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Biological Imaging Reagents Market Drivers & Restraints 2021
Table 7. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Nanotechnology h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 138. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 143. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 148. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 153. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 157. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 203. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 372. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 373. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 374. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 375. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 376. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 377. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 378. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 379. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 380. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 381. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 382. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 383. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 384. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 385. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 386. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 387. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 388. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 389. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 390. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 391. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 392. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 393. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 394. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 395. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 396. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 397. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 398. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 399. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 400. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 401. Leading 15 Biological Imaging Reagents Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 402. Bayer AG.Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Bayer AG Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 404. Thermo Fisher Scientific, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 405. Thermo Fisher Scientific, Inc. Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 406. PerkinElmer, Inc.Profile 2019 (CEO, HQ, Founded, Website)
Table 407. PerkinElmer, Inc.Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 408. Guerbet Profile 2019 (CEO, HQ, Founded, Website)
Table 409. Guerbet Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 410. Lantheus Holdings, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 411. Lantheus Holdings, Inc. Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 412. Bracco S.p.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 413. Bracco S.p.A. Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 414. GE Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 415. GE Healthcare Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 416. BD Profile 2019 (CEO, HQ, Founded, Website)
Table 417. BD Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 418. Siemens Healthineers Profile 2019 (CEO, HQ, Founded, Website)
Table 419. Siemens Healthineers Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 420. Luminex Corporation Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 421. Luminex Corporation Biological Imaging Reagents Product Offering (Segment, Product Offerings)
Table 422. Other Companies Involved in the Biological Imaging Reagents Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Biological Imaging Reagents Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Biological Imaging Reagents Market Drivers & Restraints 2021
Figure 7. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Contrast Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Nuclear Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Optical Imaging Reagents Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Fluorescent Dyes and Probes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 33. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Others Reagents Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Injectable Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Tablet Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Suspension Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Biological Imaging Reagents Market Forecast By Technology Type Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Nanotechnology Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Nanotechnology h Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Biologic Targeting Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Microfluidics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Supramolecular Chemistry Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Protein Engineering Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Biological Imaging Reagents Market Forecast By Application Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. In Vitro Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. In Vivo Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Diagnostic Laboratories Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Imaging Centers Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 128. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. Life Sciences Companies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 133. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. Academic & Research Institutes Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 138. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 143. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 148. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. Direct Tender Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 153. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Retail Sales Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. North America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. North America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. North America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. North America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. North America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. North America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. North America Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. US Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Canada Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 203. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 204. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 205. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 206. Europe Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 207. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 208. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 209. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 210. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 211. Europe Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 212. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 213. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 214. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 215. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 216. Europe Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 217. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 218. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 219. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 220. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 221. Europe Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 222. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 223. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 224. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 225. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 226. Europe Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 227. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 228. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 229. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 230. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 231. Europe Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 232. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Europe Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. UK Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Germany Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. France Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Rest of Europe Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Asia Pacific Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. Asia Pacific Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Asia Pacific Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. Asia Pacific Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Asia Pacific Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Asia Pacific Biological Imaging Reagents Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. China Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. India Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Japan Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. RoAPAC Biological Imaging Reagents Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Middle East Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Middle East Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Middle East Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Middle East Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Middle East Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Middle East Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Latin America Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Latin America Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Latin America Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Latin America Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Latin America Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Latin America Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 372. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 373. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 374. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 375. Africa Biological Imaging Reagents Market Forecast By Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 376. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 377. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 378. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 379. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 380. Africa Biological Imaging Reagents Market Forecast By Form 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 381. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 382. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 383. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 384. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 385. Africa Biological Imaging Reagents Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 386. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 387. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 388. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 389. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 390. Africa Biological Imaging Reagents Market Forecast By Technology Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 391. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 392. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 393. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 394. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 395. Africa Biological Imaging Reagents Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 396. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 397. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 398. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 399. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 400. Africa Biological Imaging Reagents Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 401. Leading 10 Biological Imaging Reagents Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Figure 402. Porter’s Five Force Analysis
Companies Profiled in the Report
1. Bayer AG
2. Thermo Fisher Scientific, Inc.
3. PerkinElmer, Inc.
4. Guerbet
5. Lantheus Holdings, Inc.
6. Bracco S.p.A.
7. GE Healthcare
8. BD
9. Siemens Healthineers
10. Luminex Corporation
List of Companies Mentioned in the Report:
1. ABT Molecular Imaging Inc.
2. ABX Advanced Biochemical Compounds Gmbh
3. Active Motif Chromeon Gmbh
4. Acusphere Inc.
5. Advanced Accelerator Applications Sa
6. Advanced Proteome Therapeutics Inc.
7. Advanced Research Technologies Inc.
8. Affibody Ab
9. Agenix Ltd.
10. Alseres Pharmaceuticals Inc.
11. Alzhyme Pty Ltd.
12. Amag Pharmaceuticals Inc.
13. American Dye Source Inc.
14. American Elements
15. Anaspec Inc.
16. Anticancer Inc.
17. Aposense
18. Areva
19. Astellas Pharma Inc.
20. Astrazeneca Ltd.
21. Atreus Pharmaceuticals Corp.
22. Atto-Tec Gmbh
23. Axxam Spa
24. Bayer Healthcare Ag
25. BBI International
26. BD
27. Beckman Coulter Inc.
28. Betaplus Radiopharmaceutials Llc
29. Bioforce Nanosciences Holdings Inc.
30. Biosceptre International Ltd.
31. Biosearch Technologies Inc.
32. Biotium Inc.
33. Biovision Inc.
34. Bracco Imaging Spa
35. Capsulution Pharma Ag
36. Cardinal Health
37. Carestream Health Inc.
38. Cellcyte Genetics
39. Cellpoint Llc.
40. Chematech Sas
41. Chemicell Gmbh
42. China Medical Technologies Inc.
43. Chromotek Gmbh
44. Cisbio Bioassays
45. Covalys Biosciences Ag
46. Covidien Plc
47. Cytodiagnostics
48. Evrogen
49. J.B. Chemicals & Pharmaceuticals Ltd.
50. Johnson & Johnson
51. Jubilant Life Sciences Ltd.
52. Nanoco Technologies Ltd.
53. Perkinelmer Inc.
54. Philips Healthcare
55. Rapidscan Pharma Solutions Inc.
56. Reade Advanced Materials
57. Siemens Ag
58. Sirigen Ltd.
59. Theragnostic Technologies Inc.
60. Thermo Fisher Scientific
List of Organizations Mentioned in the Report:
1. Food and Drug Administration (FDA)
2. European Medicines Agency (EMA)
3. World Health Organization (WHO)
4. National Institutes of Health (NIH)
5. Pharmaceuticals and Medical Devices Agency (PMDA)
6. Agência Nacional de Vigilância Sanitária (ANVISA)
7. Duke University
8. Ministry of Health, Labour and Welfare (MHLW)
9. Michigan State University
10. National Institute for Health and Clinical Excellence (NICE)
11. University of Connecticut
12. The National Medical Products Administration (NMPA)
13. Indian Council of Medical Research (ICMR)
14. The Therapeutic Goods Administration
15. The Federal Institute for Drugs and Medical Devices (BfArM)
16. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
17. Ministry of Health, Labour & Welfare(MHLW)
18. Medicines and Healthcare Products Regulatory Agency (MHRA)
19. Centre for Pharmaceutical Administration Health Sciences Authority
20. Central Drug Standard Control Organization (CDSCO)
1. Bayer AG
2. Thermo Fisher Scientific, Inc.
3. PerkinElmer, Inc.
4. Guerbet
5. Lantheus Holdings, Inc.
6. Bracco S.p.A.
7. GE Healthcare
8. BD
9. Siemens Healthineers
10. Luminex Corporation
List of Companies Mentioned in the Report:
1. ABT Molecular Imaging Inc.
2. ABX Advanced Biochemical Compounds Gmbh
3. Active Motif Chromeon Gmbh
4. Acusphere Inc.
5. Advanced Accelerator Applications Sa
6. Advanced Proteome Therapeutics Inc.
7. Advanced Research Technologies Inc.
8. Affibody Ab
9. Agenix Ltd.
10. Alseres Pharmaceuticals Inc.
11. Alzhyme Pty Ltd.
12. Amag Pharmaceuticals Inc.
13. American Dye Source Inc.
14. American Elements
15. Anaspec Inc.
16. Anticancer Inc.
17. Aposense
18. Areva
19. Astellas Pharma Inc.
20. Astrazeneca Ltd.
21. Atreus Pharmaceuticals Corp.
22. Atto-Tec Gmbh
23. Axxam Spa
24. Bayer Healthcare Ag
25. BBI International
26. BD
27. Beckman Coulter Inc.
28. Betaplus Radiopharmaceutials Llc
29. Bioforce Nanosciences Holdings Inc.
30. Biosceptre International Ltd.
31. Biosearch Technologies Inc.
32. Biotium Inc.
33. Biovision Inc.
34. Bracco Imaging Spa
35. Capsulution Pharma Ag
36. Cardinal Health
37. Carestream Health Inc.
38. Cellcyte Genetics
39. Cellpoint Llc.
40. Chematech Sas
41. Chemicell Gmbh
42. China Medical Technologies Inc.
43. Chromotek Gmbh
44. Cisbio Bioassays
45. Covalys Biosciences Ag
46. Covidien Plc
47. Cytodiagnostics
48. Evrogen
49. J.B. Chemicals & Pharmaceuticals Ltd.
50. Johnson & Johnson
51. Jubilant Life Sciences Ltd.
52. Nanoco Technologies Ltd.
53. Perkinelmer Inc.
54. Philips Healthcare
55. Rapidscan Pharma Solutions Inc.
56. Reade Advanced Materials
57. Siemens Ag
58. Sirigen Ltd.
59. Theragnostic Technologies Inc.
60. Thermo Fisher Scientific
List of Organizations Mentioned in the Report:
1. Food and Drug Administration (FDA)
2. European Medicines Agency (EMA)
3. World Health Organization (WHO)
4. National Institutes of Health (NIH)
5. Pharmaceuticals and Medical Devices Agency (PMDA)
6. Agência Nacional de Vigilância Sanitária (ANVISA)
7. Duke University
8. Ministry of Health, Labour and Welfare (MHLW)
9. Michigan State University
10. National Institute for Health and Clinical Excellence (NICE)
11. University of Connecticut
12. The National Medical Products Administration (NMPA)
13. Indian Council of Medical Research (ICMR)
14. The Therapeutic Goods Administration
15. The Federal Institute for Drugs and Medical Devices (BfArM)
16. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
17. Ministry of Health, Labour & Welfare(MHLW)
18. Medicines and Healthcare Products Regulatory Agency (MHRA)
19. Centre for Pharmaceutical Administration Health Sciences Authority
20. Central Drug Standard Control Organization (CDSCO)
Download sample pages
Complete the form below to download your free sample pages for Biological Imaging Reagents Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Biological Imaging Reagents Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
